• 名称：CEP-18770 (Delanzomib)
• 简介：CEP-18770 is a novel orally active proteasome inhibitor with a favorable tumor selectivity profile for the treatment of MM and other malignancies responsive to proteasome inhibition.
• CASNO：847499-27-8
• 分子式：C21H28BN3O5
• 分子量：413.3
• SMILES：B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O
• 保持条件：at -20°C 3 years Powder
• 同名：CEP18770
• 纯度：>98%
• 应用：Proteasome inhibitor
• 作用机制：Inhibitor